Concept4 were appointed to develop a full design proposal to support the relocation of research laboratories and office facilities from its existing location to a new purpose-built facility at the Translation & Innovation Hub (I-HUB), Imperial College London.
Concept4 worked closely with the ADCT leadership team to design laboratory & office facilities to support the planned future growth of the business. The laboratory design specification included new dedicated mechanical ventilation and extraction, piped gases, safety sinks, 3-phase power supplies, oxygen depletion monitoring, chemical resistant work benches and storage with separate write up space, shared meeting rooms and communal breakout space.
The project was delivered during the first wave of the COVID pandemic with the fitout programme and budget being maintained whilst ensuring COVID site safety practices were adhered to from start to finish.
ADC Therapeutics is a commercial-stage biotechnology company dedicated to delivering next-generation PBD-Based ADCs for those affected by cancer. With a deep understanding of ADC technology and of the oncology treatment landscape, ADC Therapeutics intends to address significant unmet medical needs and improve outcomes for those with difficult-to-treat cancers.
‘The team at Concept4 were a joy to work with from design to completion. We are thrilled with the results, delivered on time and to budget. Our state-of-the-art labs and office space provide us with a fantastic working environment, the entire team loves it, including the SVP R&D Patrick van Berkel who just couldn’t stop smiling on his first visit’Lisa Skelton (PhD), VP Global Project Management